CHIMIOTHERAPIE SEQUENTIELLE BASEE SUR L'HYPOTHESE D'UN RYTHME CIRCADIEN DE LA PROLIFERATION TUMORALEFOCAN C.1975; NOUV. PRESSE MED.; FR.; DA. 1975; VOL. 4; NO 38; PP. 2709-2712; ABS. ANGL.; BIBL. 38 REF.Article

AGRANULOCYTOSIS AND TUMOURAL FACILITATION INDUCED BY LEVAMISOLE IN A CASE OF IGG MULTIPLE MYELOMAFOCAN C.1979; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1979; VOL. 6; NO 4; PP. 263-264; BIBL. 8 REF.Article

How to accurately evaluate growth fraction potential doubling time and cell loss in animal and human tumor systems with circadian kineticsFOCAN, C.Annual review of chronopharmacology. 1990, Vol 7, pp 215-218, issn 0743-9539, 4 p.Conference Paper

DOUBLE TEST OF SPONTANEOUS ROSETTES WITH SHEEP AND MOUSE ERYTHROCYTES. STATISTICAL STUDIES AND USEFULNESS IN MALIGNANT EVOLUTIVE AND NONEVOLUTIVE LYMPHOPROLIFERATIVE DISEASES.BEAUMARIAGE ML; FOCAN C.1978; ACTA HAEMATOL.; SUISSE; DA. 1978; VOL. 59; NO 6; PP. 321-331; BIBL. 2 P.Article

Chronobiologie et marqueurs biochimiques du cancer humain = Chronobiology and biochemical markers in human cancerFOCAN, C.Transactions of the Zoological Society of London. 1987, Vol 35, Num 6, pp 951-959, issn 0084-5620Article

DISTRIBUTIONS LOGARITHMO-NORMALES DES VALEURS RELATIVES ET ABSOLUES DE LYMPHOCYTES HUMAINS FORMANT DES ROSETTES SPONTANEES EN PRESENCE D'HEMATIES DE MOUTON ET DE SOURIS CHEZ L'ADULTE NORMAL.FOCAN C; BEAUMARIAGE ML.1976; C.R. ACAD. SCI., D; FR.; DA. 1976; VOL. 283; NO 13; PP. 1567-1570; ABS. ANGL.; BIBL. 12 REF.Article

MISE EN EVIDENCE D'UN RYTHME NYCTHEMERAL DE LA DIVISION CELLULAIRE DANS DES SARCOMES INDUITS PAR LE METHYLCHOLANTHRENEFOCAN C; BARBASON H; BETZ EH et al.1973; C.R. ACAD. SCI., D; FR.; DA. 1973; VOL. 276; NO 14; PP. 2229-2232; BIBL. 16 REF.Serial Issue

USE OF SYNCHRONIZATION INDUCED BY CYCLOPHOSPHAMIDE IN A METHYLCHOLANTHRENE SARCOMA WITH CIRCADIAN PROLIFERATION TO RATIONAL SEQUENTIAL CHEMOTHERAPY.FOCAN C; BARBASON H; BETZ EH et al.1975; BIOMEDICINE; FR.; DA. 1975; VOL. 23; NO 6; PP. 230-235; ABS. FR.; BIBL. 46 REF.Article

LESIONS HEPATIQUES ET TROUBLES DE LA COAGULATION DANS L'EMBOLIE PULMONAIRE. (ETUDE ANATOMO-CLINIQUE D'UN CAS).FOCAN C; BURY J; MARCELLE R et al.1976; ACTA CARDIOL.; BELG.; DA. 1976; VOL. 31; NO 6; PP. 505-517; ABS. ANGL. ESP.; BIBL. 1 P. 1/2Article

INFLUENCE DU RYTHME NYCTHEMERAL DES DIVISIONS CELLULAIRES SUR L'EFFICACITE DE LA CYCLOPHOSPHAMIDE CONTRE DES SARCOMES INDUITS PAR LE METHYLCHOLANTHRENEFOCAN C; BARBASON H; BETZ EH et al.1973; C.R. ACAD. SCI, D; FR.; DA. 1973; VOL. 276; NO 13; PP. 2105-2108; BIBL. 18REF.Serial Issue

CELL PROLIFERATION IN A MALIGNANT ANGIOENDOTHELIOMA DURING SEQUENTIAL CHEMOTHERAPYPIERARD GE; FOCAN C; LAPIERE CM et al.1979; J. CUTAN. PATHOL.; DNK; DA. 1979; VOL. 6; NO 6; PP. 479-485; BIBL. 21 REF.Article

LA LAPAROTOMIE DANS LES HEMATOSARCOMES ANALYSE DE 76 SPLENECTOMES.LEMAIRE M; FOCAN C; HUGUES J et al.1975; ACTA CLIN. BELG.; BELG.; DA. 1975; VOL. 30; NO 4; PP. 249-253; ABS. ANGL. NEERL.; BIBL. 13 REF.Article

Administration continue de drogues en chimiothérapie anticancéreuse : bases théoriques et revue de la littérature = Continuous infusion chemotherapy in cancerLONGREE, L; FOCAN, C.RMLG. Revue médicale de Liège. 1993, Vol 48, Num 5, pp 270-278, issn 0370-629XArticle

CLINICAL AND HISTOLOGICAL STAGING AS PROGNOSTIC DETERMINANTS IN ADVANCED CUTANEOUS T CELL LYMPHOMAS TREATED BY SEQUENTIAL POLYCHEMOTHERAPY WITH BLEOMYCIN, VINBLASTINE AND PREDNISONEFOCAN C; CRYNS LENAIN E; BOUHY F et al.1982; DERMATOLOGICA; ISSN 0011-9075; CHE; DA. 1982; VOL. 165; NO 2; PP. 141-144; BIBL. 19 REF.Article

INCLUSION OF VINDESINE IN SEQUENTIAL CHEMOTHERAPY BASED UPON THE CIRCADIAN RHYTHM OF HUMAN SOLID TUMORSFOCAN C; LE HUNG S; CLAESSENS JJ et al.1979; J. CANCER RES. CLIN. ONCOL.; DEU; DA. 1979; VOL. 95; NO 1; PP. 99-100; BIBL. 5 REF.Article

COMBINATION CHEMOTHERAPY IN HODGKIN'S AT ADVANCED STAGES.FOCAN C; BRICTEUX N; LEMAIRE M et al.1975; ACTA CLIN. BELG.; BELG.; DA. 1975; VOL. 30; NO 4; PP. 298-309; ABS. FR.; BIBL. 1 P. 1/2Article

CIRCADIAN VARIABILITY OF KINETICS IN A TRANSPLANTABLE ISLET-CELL TUMOR OF THE GOLDEN HAMSTERFOCAN C; SCHYNS MOSEN J; LUYCKX A et al.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 104; NO 3; PP. 197-206; BIBL. 2 P.Article

Pharmaco-economic comparative evaluation of combination chronotherapy vs. standard chemotherapy for colorectal cancerFOCAN, C.Chronobiology international. 2002, Vol 19, Num 1, pp 289-297, issn 0742-0528Article

Effet synchroniseur du rythme circadien de la corticostérone sur la vitesse de synthèse du DNA dans le foie du jeune rat = Circadian corticosterone synchronizing effect in the DNA synthesis rate of the young rat liverBARBASON, H; FOURRE, F; FOCAN, C et al.Pathologie et biologie. 2003, Vol 51, Num 4, pp 210-211, issn 0369-8114, 2 p.Article

Cancer associated retinopathy (CAR) : Présentation de deux cas cliniques et revue de la littérature = The cancer associated retinopathy (CAR)MATUS, G; DICATO, M; FOCAN, C et al.RMLG. Revue médicale de Liège. 2007, Vol 62, Num 3, pp 166-169, issn 0370-629X, 4 p.Article

Oral etoposide preceding cisplatin in advanced non small cell lung cancer (NSCLC). A phase II studyFOCAN, C; VANDERMOTEN, G; BOOSSY, J et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 9, pp 1515-1520, issn 0277-5379Article

Importance du comportement circadien de l'hôte pour la genèse et l'évolution des cancers. Une revue = Circadian behaviour of host versus tumour outcome. A reviewFOCAN, C; LEVI, F; INNOMMATO, P et al.Pathologie et biologie. 2007, Vol 55, Num 3-4, pp 178-180, issn 0369-8114, 3 p.Conference Paper

BRONCHOSPASME, SIGNE REVELATEUR DE L'EMBOLIE PULMONAIREBROUX R; BURY J; MARCELLE R et al.1976; ARCH. MAL. COEUR VAISS.; FR.; DA. 1976; VOL. 69; NO 4; PP. 419-425; ABS. ANGL. ALLEM. ESP.; BIBL. 25 REF.Article

Levamisole or placebo after effective chemotherapy for remission and survival prolongation in advanced human solid tumors―A double-blind randomized trialFOCAN, C; SCHYNS-MOSEN, J; FOCAN-HENRARD, D et al.Acta oncologica (Stockholm). 1989, Vol 28, Num 1, pp 105-106, issn 0284-186XArticle

NEUROLOGICAL TOXICITY OF VINDESINE USED IN COMBINATION CHEMOTHERAPY OF 51 HUMAN SOLID TUMORSFOCAN C; OLIVER R; LE HUNG S et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 2; PP. 175-181; BIBL. 60 REF.Article